Over-the-counter drops remain a cornerstone of dry eye treatment—but only if they are tailored, evidence-based, and designed to stabilize the tear film and support ocular surface health, as TFOS DEWS III emphasizes. With Systane® PRO PF, patients experience a unique formula that is designed to address all types of dry eye disease.
Formulated with a triple-action blend—including an HP-guar gel-like meshwork, anionic phospholipids, hyaluronic acid, and propylene glycol—Systane® PRO PF mimics natural tear film to stabilize the lipid layer and reduce tear evaporation.
In a 30-day clinical trial, a single drop provided statistically significant symptom relief for up to 12 hours, with 42% of patients experiencing meaningful relief. Continued use demonstrated measurable improvements in tear film stability and symptom-related quality of life.
Backed with a Toronto Blue Jays partnership, patients are likely already aware of its powerful formula—are you? Read the full report below and visit mydryeye to explore more resources that give you and your practice the clinical edge.
